COVID-19 AND COMORBIDITIES

Methods: In this analysis the data was obtained from the hospital information system (BIS), involving patients who were hospitalized for treatment of moderate to severe COVID-19 infection at the Infectious Diseases Clinic of the Tuzla University Clinical Center (UCC) between January 1 and April 8, 2021. SUBJECTS AND METHODS Subjects A retrospective observational study was conducted that included data from BIS from 400 subjects who were hospitalized for treatment of moderate to severe COVID-19 at the Infectious Diseases Clinic of the UCC Tuzla in the period between January 1 and April 8, 2021. The study was approved by the Ethics Committee of UCC Tuzla before data collection. Methods The following data analyzed for all 400 subjects: age, sex, symptoms (fever, cough, headache, sore throat, dyspnea, weakness, loss of appetite, loss of sense of smell and taste, vomiting, diarrhea, dizziness), presence of comorbidities during hospitalization (cardiovascular, gastrointestinal, nephrological, endocrinological, hematological, pulmonary, neurological, surgical, orthopedic, urological, psychiatric, ophthalmological, otorhinolaryngological).